Experimental group:remimazolam
Sponsors
The First Affiliated Hospital of Anhui Medical University, Taizhou Hospital of Zhejiang Province, Xiangtan Central Hospital, Beijing Tsinghua Changgung Hospital, The First Affiliated Hospital of Zhengzhou University
Conditions
Acute strokeAnesthesia with electroresection of the prostateGeneral anesthesiaNonePostoperative deliriumelderly patients with mechanical ventilationhip surgeryhypertension
Phase 1
Phase 4
Comparison of remimazolam and propofol on incidence of postoperative delirium after hip surgery under general anesthesia
RecruitingChiCTR2000038223
Start: 2021-06-30Updated: 2022-10-17
Half effective dose of remimazolam in painless colonoscopy
RecruitingChiCTR2000040900
Start: 2021-01-01Updated: 2021-04-12
Comparison of clinical efficacy of remazolam and propofol in patients with acute stroke after endovascular treatment
RecruitingChiCTR2100045420
Start: 2021-04-20Updated: 2021-11-29
Effect of Remimazolam on Postoperative Delirium in Elderly Patients undergoing Hip Surgery: A Prospective, Randomized, Controlled Study
RecruitingChiCTR2100050511
Start: 2021-09-01Updated: 2022-05-02
To determine ED50 and ED95 of remimazolam toluenesulfonate to induce auxiliary sedation in elderly patients undergoing spinal anesthesia
RecruitingChiCTR2100051912
Start: 2021-10-10Updated: 2022-06-27
Perioperative management of remimazolam for general anesthesia and the effect on patient prognosis
RecruitingChiCTR2200064255
Start: 2022-10-01Updated: 2023-05-15
A study of remimazolam on sedation in elderly patients with mechanical ventilation
RecruitingChiCTR2300078823
Start: 2022-07-01Updated: 2024-01-14
Unknown Phase
Exploration of the Effective Dose of Remimazolam Besylate in Obese Patients During General Anesthesia Induction and Evaluation of Its Perioperative Application Effects
Active, not recruitingChiCTR2400094557
Start: 2025-01-01Updated: 2025-01-06
Study on the Efficacy and Safety of Remimazolam Besylate Combined with Alfentanil in Elderly Patients Undergoing Flexible Bronchoscopy
Active, not recruitingChiCTR2500112287
Start: 2025-12-01Updated: 2025-11-17